Summary
A study into the prevalence and treatment of dyskinesia in Parkinson’s disease (PD) patients was performed with 380 PD specialists-completed interviews relating to PD and retrospectively completed 1900 patient record forms for patients with dyskinesia. Physicians reported, that 34% of their PD patients experience dyskinesia, 57% of dyskinetic PD patients were affected by moderately-to-completely disabling dyskinesia. Treatment of dyskinesia was looked upon as not satisfactory, fractionating of levodopa dose was used as first choice therapeutic option of dyskinesia.
Article PDF
Avoid common mistakes on your manuscript.
References
JE Ahlskog MD Muenter (2001) ArticleTitleFrequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448–458 10.1002/mds.1090 Occurrence Handle10.1002/mds.1090 Occurrence Handle1:STN:280:DC%2BD3MzitVCmtg%3D%3D Occurrence Handle11391738
S Chapuis L Ouchchane O Metz L Gerbaud F Durif (2005) ArticleTitleImpact of the motor complications of Parkinson’s disease on the quality of life Mov Disord 20 224–230 10.1002/mds.20279 Occurrence Handle10.1002/mds.20279 Occurrence Handle15384126
S Fahn D Oakes I Shoulson K Kieburtz A Rudolph A Lang CW Olanow C Tanner K Marek (2004) ArticleTitleLevodopa and the progression of Parkinson’s disease N Engl J Med 351 2498–2508 10.1056/NEJMoa033447 Occurrence Handle10.1056/NEJMoa033447 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGksbnE Occurrence Handle15590952
CW Olanow RL Watts WC Koller (2001) ArticleTitleAn algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines Neurology 56 S1–S88 Occurrence Handle1:STN:280:DC%2BD3MzkslSlsw%3D%3D Occurrence Handle11402154
R Pahwa SA Factor KE Lyons WG Ondo G Gronseth H Bronte-Stewart M Hallett J Miyasaki J Stevens WJ Weiner (2006) ArticleTitlePractice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 66 IssueID7 983–995 10.1212/01.wnl.0000215250.82576.87 Occurrence Handle10.1212/01.wnl.0000215250.82576.87 Occurrence Handle1:STN:280:DC%2BD283gtVSksQ%3D%3D Occurrence Handle16606909
O Rascol DJ Brooks AD Korczyn PP De Deyn CE Clarke AE Lang M Abdalla (2006) ArticleTitleDevelopment of dyskinesias in a 5-year trial of ropinirole and L-dopa Mov Disord 21 1844–1850 10.1002/mds.20988 Occurrence Handle10.1002/mds.20988 Occurrence Handle16958094
A Schrag N Quinn (2000) ArticleTitleDyskinesias and motor fluctuations in Parkinson’s disease. A community-based study Brain 123 IssueIDPt 11 2297–2305 10.1093/brain/123.11.2297 Occurrence Handle10.1093/brain/123.11.2297 Occurrence Handle11050029
FP Silva-Junior P Braga-Neto MF Sueli VM de Bruin (2005) ArticleTitleAmantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study Parkinsonism Relat D 11 449–452 10.1016/j.parkreldis.2005.05.008 Occurrence Handle10.1016/j.parkreldis.2005.05.008
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, T., Woitalla, D., Russ, H. et al. Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease. J Neural Transm 114, 1023–1026 (2007). https://doi.org/10.1007/s00702-007-0718-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0718-4